Journals / Ankara Medical Journal / 2020 / Cilt: 20 - Sayı: 1

EVALUATION OF COMORBIDITIES IN ADULT PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

ERİŞKİN TOPLUMDA GELİŞEN PNÖMONİ OLGULARINDA KOMORBİDİTELERİN DEĞERLENDİRİLMESİ

Pages
116–122
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It will be beneficial to increase the number of geriatric centers in our country.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study is the evaluation of comorbidities in hospitalized patients with communityacquired pneumonia (TGP) and to investigate in the light of the literature.
📊
Key Findings & Data:Materials and Methods: This retrospective, cross-sectional study was conducted in the Department of Chest Diseases. 142 patients with TGP between 2017-2019 were enrolled in the study.
💡
Conclusion & Impact:It will be beneficial to increase the number of geriatric centers in our country.
🔬Design:Research Article
📍Scope:2017-2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study is the evaluation of comorbidities in hospitalized patients with communityacquired pneumonia (TGP) and to investigate in the light of the literature. Materials and Methods: This retrospective, cross-sectional study was conducted in the Department of Chest Diseases. 142 patients with TGP between 2017-2019 were enrolled in the study. The data were obtained from the medical records of the patients. Demographic features, comorbidities and clinical findings of the patients were recorded. In the subgroup analysis, patients aged 65 and over were separately evaluated and their comorbid status was examined. Results: The mean age of 142 patients were 59.68 ± 20.35 (min 18-max 95). There were 54 (38%) women and 88 (62%) men. Comorbidities were presented in 80 patients (56.30%). The most common comorbidities were cardiovascular diseases (41.50%), diabetes mellitus (23.90%) and chronic lung diseases (19%). Half of the patients with TGP were 65 years old or older. The patients were divided into two groups according to over 65 years and under. Comorbidities were compared in two groups. Comorbidities were found to be higher in patients over the age of 65 years as expected (p=0.001). There were significant differences between the two groups in terms of cardiovascular diseases and diabetes mellitus (p=0.001, p=0.049, respectively). There was a positive correlation between age and comorbidities (p=0.001, r=0.512, respectively). Conclusion: Comorbidities in TGP are very important in determining the severity of the disease and treatment. Comorbidities are accompanied in most patients, especially in the increasing population of elderly patients. In this study, half of the patients hospitalized due to TGP consisted of patients aged 65 and over. In these patients should evaluate swallowing function especially in patients with neurological diseases. Also, primary health care and vaccination are important. Timely measures will ensure the elderly population to live more comfortably and reduce health costs. It will be beneficial to increase the number of geriatric centers in our country.

Özet

Amaç: Bu çalışmanın amacı toplum kökenli pnömoni nedeni ile (TGP) hastanede yatan olgulardakomorbiditeleri değerlendirmek ve literatür ışığında incelemektir.Materyal ve Metot: Bu retrospektif, kesitsel çalışmaya 2017-2019 yılların arasında Göğüs HastalıklarıKliniği’nde takip edilmiş TGP olguları dahil edildi. Veriler hastaların medikal kayıtlarından elde edildi. Olgularındemografik özellikleri, komorbid durumları, klinik bulguları kaydedildi. Subgrup analizinde 65 yaş ve üstüolgular ayrıca değerlendirilerek, komorbid durumları incelendi.Bulgular: Çalışmaya dahil edilen 142 hastanın yaş ortalaması 59,68±20,35 (min 18-maks 95). Olguların 54’ü(%38) kadın, 88’i (%62) erkekti. 80’inde (%56,30) eşlik eden komorbidite mevcuttu. En sık komorbiddurumlar sırasıyla; kardiyovaskuler hastalıklar (%41,50), diabetes mellitus (%23,90) kronik akciğerhastalıklarıydı (%19). Bu çalışmaya dahil edilen olguların 71’i (%50) 65 yaş ve üzerindeydi. 65 yaş üstü ve altıolgular komorbiditeler açısından değerlendirildi. ≥65 yaş üstü olgularda beklenildiği gibi komorbiditelerindaha fazla olduğu görüldü (p=0,001). Özellikle kardiyovaskuler hastalıklar ve diabetes mellitus açısındananlamlı farklılık saptandı (sırasıyla; p=0,001, p=0,049). Yaş ile komorbidite arasında pozitif korelasyon olduğugörüldü (sırasıyla; p=0,001, r=0,512).Sonuç: TGP’de komorbiditeler hastalığın ağırlığının belirlenmesi ve tedavi kararında oldukça önemlidir.Özellikle yaşlı nüfusun arttığı günümüzde komorbid durumlar hastaların çoğunda eşlik etmektedir. Buçalışmada TGP nedeni ile yatış yapılan olguların yarısı 65 yaş ve üzerinde olduğu görüldü. Bu olgulardakoruyucu sağlık hizmetleri, özellikle nörolojik hastalığı olanlarda yutma fonksiyonun değerlendirilmesi veaşılama önemlidir. Zamanında önlemlerin alınması yaşlı nüfusun daha konforlu olarak yaşamına olanaksağlayacaktır ve sağlık maliyetlerini azaltacaktır. Ülkemizde geriatrik merkezlerin sayısının artırılması faydalıolacaktır

🔖

Cite This Article

KARALEZLİ, A., PARLAK, E. Ş. (2022). EVALUATION OF COMORBIDITIES IN ADULT PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Ankara Medical Journal, Cilt: 20 - Sayı: 1, 116–122. https://ajindex.com/articles/441791

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kolditz M, Ewig S. Community-Acquired Pneumonia in Adults. Dtsch Arztebl Int 2017;114:838-48
  2. Arias Fernández L, Pardo Seco J, Cebey-López Met al; NEUMOEXPERTOS group. Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain. BMC Infect Dis 2019;19:973-80
  3. Metlay JP, Waterer GW, Long AV, et al.; on behalf of the American Thoracic Society and Infectious Diseases Society of America. Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine 2019;200:46-67
  4. Bülbül Y. Türkiye’de Toplumda Gelişen Pnömoni Verileri. Güncel Göğüs Hastalıkları Serisi 2014;2:1- 10 5. Cömert S, Doğan C, Fidan A, Salepçi B, Kıral N, Çağlayan B. The Correlation of Different Pneumonia Severity Classifications with Each Other According to the Indications for Hospitalization Turk Toraks Derg 2012;13:158-62
  5. Rivero-Calle I, Cebey-López M, Pardo-Seco J, et al. Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project). BMJ Open Respir Res 2019;6:e000359
  6. Özlü T, Karahan H, Bülbül Y, Özsu S, Öztuna F. Servise Yatırılarak Tedavi Edilen ve Risk Faktörü Taşıyan Erişkin Toplum Kökenli Pnömoni (TKP) Hastalarında Moksifloksasin Monoterapisi ile Seftriakson+Klaritromisin Kombinasyonunun, Etkinlik ve Güvenilirliğinin Karşılaştırılması. Solunum 2011;13:9–13
  7. Erdede M, Denizbasi A, Onur O, Guneysel O. Do we really need blood cultures in treating patients with community-acquired pneumonia? Bratisl Lek Listy. 2010;111:286-9
  8. Bircan A, Sütçü R, Gökırmak M, Hiçyılmaz H, Akkaya A, Öztürk Ö. Total Antioxidant Capacity and CReactive Protein Levels in Patients with Community-Acquired Pneumonia. Turk J Med Sci 2008;38:537-44
  9. Pişkin N, Aydemir H, Oztoprak N, Akduman D, Celebi G, Seremet Keskin A. [Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia]. Mikrobiyol Bul 2009;43:597-606
  10. Remington LT, Sligl WI. Community-acquired pneumonia. Curr Opin Pulm Med. 2014;20:215-24
  11. Fung HB, Monteagudo-Chu MO. Community-acquired pneumonia in the elderly. Am J Geriatr Pharmacother. 2010;8:47-62
  12. Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review